Review: doxorubicin delivery systems based on chitosan for cancer therapy

Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy

(2010) Crispin R. Dass et al.   CANCER BIOLOGY & THERAPY

Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model

(2010) Crispin R. Dass et al.   CANCER BIOLOGY & THERAPY

Dextran-Coated Gold Nanoparticles for the Assessment of Antimicrobial Susceptibility

(2008) Sudip Nath et al.   ANALYTICAL CHEMISTRY

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy

(2008) Jong-Ho Kim et al.   BIOMATERIALS

In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin

(2008) Masato Watanabe et al.   JOURNAL OF CONTROLLED RELEASE

c-Jun Is Critical for the Progression of Osteosarcoma: Proof in an Orthotopic Spontaneously Metastasizing Model

(2008) C. R. Dass et al.   MOLECULAR CANCER RESEARCH

c-Jun knockdown sensitizes osteosarcoma to doxorubicin

(2008) C. R. Dass et al.   MOLECULAR CANCER THERAPEUTICS

Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin

(2007) Fu-Qiang Hu et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery

(2007) Yiyun Cheng   Frontiers in Bioscience-Landmark

Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin

(2007) Yi-Qing Ye et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS